10-Q: HealthStream Reports Strong Q1 2026 Growth

HealthStream Inc. announced a 10.5% increase in Q1 2026 revenue to $81.2 million, driven by subscription services and recent acquisitions.

Summary

• HealthStream, Inc. reported first-quarter 2026 revenues of $81.2 million, an increase of 10.5% compared to $73.5 million in the first quarter of 2025.
• Operating income surged by 71.6% to $7.5 million, up from $4.4 million in the prior year's quarter.
• Net income rose by 36.4% to $5.9 million, resulting in diluted earnings per share of $0.20, an increase from $0.14 in Q1 2025.
• Adjusted EBITDA grew by 24.1% to $20.1 million, compared to $16.2 million in Q1 2025.
• The company completed two acquisitions in late 2025: Virsys12 and MissionCare Collective, which contributed to revenue growth.
• Capital expenditures for the quarter were $7.5 million, down from $8.8 million in Q1 2025.
• The company repurchased $5.0 million of its common stock under a previous program and initiated a new $10.0 million repurchase program in March 2026.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive report, with significant year-over-year growth in key financial metrics and successful integration of recent acquisitions.

Positives

• Revenue growth of 10.5% to $81.2 million in Q1 2026.
• Significant operating income increase of 71.6% to $7.5 million.
• Net income growth of 36.4% to $5.9 million.
• Diluted EPS increased to $0.20 from $0.14 in the prior year.
• Adjusted EBITDA increased by 24.1% to $20.1 million.
• Successful integration of Virsys12 and MissionCare acquisitions contributing to revenue.
• Positive cash flow from operations of $27.1 million.
• Continued dividend payments and share repurchases demonstrating commitment to shareholder returns.

Negatives

• Interest income decreased due to lower cash balances and interest rates.
• Effective tax rate increased to 24% in Q1 2026 from 17% in Q1 2025.
• Days Sales Outstanding (DSO) increased slightly to 39 days from 37 days.

Risks

• Macroeconomic and regulatory challenges in the healthcare industry, including potential government cuts to healthcare spending and changes to insurance access.
• Inflationary pressures affecting customer cost structures and potentially leading to delays in purchasing or non-renewals.
• Uncertainty surrounding potential policy, regulatory, and economic shifts impacting healthcare providers.
• The potential for future acquisitions or strategic investments to have a dilutive effect on earnings per share and adversely affect stock price.
• The revolving credit facility contains financial covenants that could restrict future borrowing if not met.

Future Outlook

The company anticipates that its existing cash, cash equivalents, marketable securities, cash generated from operations, and available borrowings under its revolving credit facility will be sufficient to meet anticipated working capital needs, new product development, dividend payments, potential share repurchases, and capital expenditures for at least the next 12 months and for the foreseeable future. Future acquisitions or strategic investments may be funded through cash, stock, or debt, and could have a dilutive effect.

Management Comments

• The Company is focused on helping individuals and organizations in healthcare meet their ongoing learning, clinical development, credentialing, and scheduling needs, whether through the Company's enterprise applications or emerging career networks.
• We believe that our single platform strategy, as represented by hStream, is the best way to realize our mission of improving the quality of care by developing the people who deliver care and the best way to create value for our shareholders in the process.
• Revenues of $81.2 million, up 10.5% from $73.5 million in the first quarter of 2025
• Operating income of $7.5 million, up 71.6% from $4.4 million in the first quarter of 2025
• Net income of $5.9 million, up 36.4% from $4.3 million in the first quarter of 2025
• Earnings per share (EPS) of $0.20 per share (diluted), up from $0.14 per share (diluted) in the first quarter of 2025
• Adjusted EBITDA of $20.1 million, up 24.1% from $16.2 million in the first quarter of 2025

Industry Context

StockSavvy.ai notes that HealthStream's performance aligns with the ongoing digital transformation trend in the healthcare sector, where SaaS solutions are increasingly adopted to improve operational efficiency and patient care outcomes. The company's focus on a unified platform strategy (hStream) is a key differentiator in a competitive landscape.

Comparison to Industry Standards

• HealthStream's revenue growth of 10.5% in Q1 2026 outpaces the general SaaS market growth rate, which has seen some moderation.
• The company's operating income margin improvement is notable, especially when compared to other healthcare IT companies that may be investing heavily in R&D or facing pricing pressures.
• The integration of acquisitions (Virsys12 and MissionCare) is a common strategy in the healthcare IT sector to expand service offerings and market reach, similar to moves by competitors like Cerner (now Oracle Health) or Epic Systems in expanding their platforms.

Legal Proceedings

• None disclosed in the filing.

Stakeholder Impact

• Shareholders: Benefit from increased revenue, operating income, net income, EPS, and ongoing dividend payments and share repurchases.
• Employees: Potential for bonuses tied to financial performance as outlined in the 2026 Cash Incentive Bonus Plan.
• Customers: Benefit from enhanced SaaS solutions and platform integration, potentially leading to improved business and clinical outcomes.
• Suppliers/Creditors: Continued operations and financial stability suggest ongoing business relationships.

Next Steps

• Continue to integrate Virsys12 and MissionCare Collective acquisitions.
• Monitor macroeconomic and regulatory changes impacting the healthcare industry.
• Manage cash flow and liquidity to support operations, dividends, and potential future acquisitions.
• Renew the revolving credit facility before its expiration on October 6, 2026.
• Continue share repurchases under the new $10.0 million program.

Key Dates

Recommendation

The company demonstrates strong operational performance and growth, but the healthcare industry faces significant macroeconomic and regulatory headwinds. While the Q1 results are positive, the forward-looking outlook requires careful monitoring of these external factors. A 'hold' recommendation reflects a balanced view of current performance against potential future uncertainties.

Keywords

HealthStream, HSTM, 10-Q, Quarterly Report, Healthcare Technology, SaaS, Financial Results, Revenue Growth, Acquisitions, Adjusted EBITDA, Sarbanes-Oxley